Award
National Cancer Institute 6R15CA268200-03
Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment
Recipient
National Cancer Institute (NCI)
Award Amount
$422,018.00
Ceiling
$422,018.00
Awarded
January 25, 2023
Identifier
6R15CA268200-03
Award for research project to optimize aminolevulinic acid for fluorescence-guided tumor resection and treatment of gliomas, improving cancer surgery outcomes.
Description
This project focuses on optimizing aminolevulinic acid for fluorescence-guided resection of gliomas, aiming to improve cancer surgery outcomes through enhanced tumor fluorescence and photodynamic therapy using FDA-approved agents like lapatinib in combination with ALA.